-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, PnE9gIZFUCALt0PmjU8ZkxUjqCnLzqRzwslNbvNxuLxHWQUPojxr0l9o2kNard0h W+OLeputPtIsEZb6WIqgTw== 0000849043-04-000041.txt : 20040428 0000849043-04-000041.hdr.sgml : 20040428 20040428144038 ACCESSION NUMBER: 0000849043-04-000041 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20030519 FILED AS OF DATE: 20040428 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NEUROGEN CORP CENTRAL INDEX KEY: 0000849043 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 222845714 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 35 NORTHEAST INDUSTRIAL RD CITY: BRANFORD STATE: CT ZIP: 06405 BUSINESS PHONE: 2034888201 MAIL ADDRESS: STREET 1: 35 NORTHEAST INDUSTRIAL RD CITY: BRANFORD STATE: CT ZIP: 06405 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BUTLER ROBERT N CENTRAL INDEX KEY: 0001070129 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-18311 FILM NUMBER: 04760116 BUSINESS ADDRESS: STREET 1: INTERNATIONAL LONGEVITY CTR C/O NY ACADE STREET 2: 1216 5TH AVE STE 552 CITY: NEW YORK STATE: NY ZIP: 10029 BUSINESS PHONE: 2127248454 MAIL ADDRESS: STREET 1: INTERNATIONAL LONGEVITY CTR C/O NY ACADE STREET 2: 1216 5TH AVE STE 552 CITY: NEW YORK STATE: NY ZIP: 10029 4 1 edgar.xml PRIMARY DOCUMENT X0202 4 2003-05-19 0000849043 NEUROGEN CORP NRGN 0001070129 BUTLER ROBERT N 35 NE INDUSTRIAL ROAD BRANFORD CT 06405 1 0 0 0 Stock Options (Right to buy) 4.25 2003-05-19 4 A 0 1500 0 A 2013-05-19 Common Stock 1500 1500 D Pursuant to the Neurogen Corporation 2000 Non-Employee Directors Stock Option Program, the options vest in twelve equal monthly installments on the last day of each month, begining the last day of the month in which the options were granted. Stephen Davis, Attorney-in-fact 2004-04-28 EX-24 2 bulter.txt POWER OF ATTORNEY POWER OF ATTORNEY The undersigned hereby appoints Stephen R. Davis, EVP and Chief Business Officer of Neurogen Corporation, his or her attorney-in-fact and agent in any and all capacities to execute for and on his or her behalf filings with the Securities and Exchange Commission on Forms 3, 4 or 5 pursuant to Section 16 of the Securities and Exchange Act of 1934, as amended, to the extent that such filings relate to the undersigned's status as a director or officer of Neurogen Corporation. The undersigned further appoints Stephen R. Davis his or her attorneyin fact and agent to execute any and all amendments to such filings as such attorney-in-fact and agent deems appropriate. The undersigned hereby grants to such attorney-in-fact and agent full power and authority to do and perform each and every act necessary or desirable as the undersigned could do in person, hereby ratifying and confirming all that such attorney in fact and agent may lawfully do or has done by virtue hereof. This Power of Attorney shall become effective as of February 12, 2001. /s/ ROBERT N. BULTER, M.D. _____________________________ Robert N. Bulter, M.D. -----END PRIVACY-ENHANCED MESSAGE-----